Skip over navigation

Rare Cancers Europe logo

  • About Rare Cancers
    • Definition of Rare Cancers
    • "Families" and List of Rare Cancers
    • The Burden and the Challenges of Rare Cancers
    • The Added Value of Research on Rare Cancers
  • About the Campaign - Objectives
  • Call to Action
    • Full text
    • Signatories
  • Political Recommendations
  • EU initiatives
  • How to get involved
  • News
    • 24 May 2013: International clinical trials setting for rare cancers: organisational and regulatory constraints—the EORTC perspective
    • 21 November 2012: Joint Statement on EU Clinical Trials Regulation
    • 3 October 2012: Survey Open: Access to Rare Cancer Care in the EU – Have Your Say!
    • 20 July 2012: International survey on Pathology in Rare Cancers launched
    • 12 June 2012: U.S. NCI issues guidance for deliberations on rare cancer trial closures
    • 4 June 2012: Rare cancer research project announces world’s largest release of human cancer genome data
    • 2 April 2012: Cancer Cell Line Encyclopedia may help to improve rare cancer research
    • 27 March 2012: European Alliance for Personalised Medicine calls for early access to personalised medicine
    • 12 March 2012: ESMO Conference on Sarcoma and GIST: Doctors lack awareness of rare forgotten cancers
    • 21 February 2012: European conference explores ways to improve clinical research on rare cancers
    • 15 February 2012: International Childhood Cancer Day: Calls for policy changes
    • 24 November 2011: International Rare Cancers Initiative: EORTC – UK – US Global Collaboration
    • 16 November 2011: Recommendations on Quality Criteria for Centres of Expertise for Rare Diseases adopted by EUCERD
    • 10 November 2011: EU consultation to improve recognition of cross-border prescriptions
    • 24 September 2011: Rare Cancers Europe: New name and new action
    • 24 September 2011: European Multidisciplinary Cancer Congress highlights challenges posed by rare cancers
    • 12 July 2011: EP Workshop on Rare Cancers: The Added Value of Closer Cooperation
    • 20 May 2011: European Platform for Rare Disease Registries
    • 31 March 2011: EurocanPlatform for cross border cancer research launched
    • 22 March 2011: EU Register of Clinical Trials launched Online
    • 15 March 2011: European childhood cancer research in danger
    • 28 February 2011: Rare Disease Day – Focus on Health Inequalities
    • 15 February 2011: MEPs remember Children with Cancer
    • 12 January 2011: EP Meeting: Challenges of Rare Cancers
    • 27 November 2010: Open Letter concerning 2011 UN Summit on Non-Communicable Diseases
    • 9 October 2010: ESMO Rare Cancers Press Briefing
    • 9 October 2010: ESMO 2010 Rare Cancers Press Briefing Videos
    • 7 October 2010: Underestimated Obstacles to Rare Cancer Care
    • 5 October 2010: EP Meeting: Orphan Drugs for Rare Cancers
    • 13 September 2010: European Action Against Rare Cancers Secretariat
    • 9 December 2009: EU Committee of Experts on Rare Diseases
    • 24 June 2009: Launch of European Action Against Rare Cancers
    • 10 December 2008: Rare cancers are common; optimal care is not
  • Rare Cancers Conference 2012
  • Surveys
  • Events
  • Cooperating organisations
    • Campaign Organisation Committee
    • Governance principles
    • Video testimonials from Cooperating organisations
    • Quotes from the Cooperating organisations
  • Corporate supporters
  • Links
    • General Cancer Patient Support Organisations and Sites
    • Rare Cancer Type-Specific Patient Support Organisations and Sites
    • General Professional Organisations, Research Organisations and Sites
    • Cancer Type-Specific Professional Organisations, Research Initiatives and Sites
    • Clinical Practice Guidelines for Professionals and Guides for Patients
  • Campaign materials
  • Contact us

28 February 2011: Rare Disease Day – Focus on Health Inequalities

February 28th, 2011 is Rare Disease Day. All over the world, rare disease patient organisations and their partners will join forces to create awareness of rare diseases and the millions of people affected by them.

Rare diseases are life-threatening or chronically debilitating diseases. Due to the low prevalence of each disease, medical experts are rare, knowledge is scarce, care offering inadequate, and research limited. Very few cures exist. While the diseases are rare, collectively they affect more than 60 million people in Europe and the US alone. Despite their great overall number, rare disease patients are the orphans of health systems, often denied diagnosis, treatment and the benefits of research.

To help raise awareness, the international Rare Disease Day campaign was initiated by the European Organisation for Rare Diseases (EURORDIS) in 2008, and since has been annually organised on the last day of February by EURORDIS, in conjunction with 25 rare disease national alliances, together representing over 1,000 patient groups.

This year’s focus is on health inequalities. "Most rare disease patients spend years wandering through the maze of health systems to find an accurate diagnosis. Many are fighting to obtain life-saving treatments or to be reimbursed by their health authorities. Others are denied access to specialised services and to disability compensation. They have further difficulties finding a job, getting into school, obtaining a loan or accessing life insurance," says EURORDIS’ Chief Executive Officer Yann Le Cam.

To further the objective of equal care for rare disease patients, EURORDIS is organising a one-day conference in Brussels in partnership with the European Commission, addressing the issue of health inequalities and discussing mitigating measures. Ms. Antonyia Parvanova, MEP and shadow rapporteur on the new EU Directive on Cross-Border HealthCare and Patient Mobility, will participate in the conference. The programme will spotlight examples of inequalities, such as the absence of widespread neonatal screening in Romania for phenylketonuria, a rare disease that is systematically screened for in most of Europe; the disparities in life expectancy for cystic fibrosis patients between European countries; the unequal access to new therapeutic approaches for rare cancer patients leading to variations in survival rates across Europe.

February 28th, 2011 will mark the fourth international Rare Disease Day coordinated by EURORDIS, together with rare disease national alliances and patient groups from more than 40 countries worldwide. Awareness-raising activities are being planned throughout Europe, USA, China, Japan, Colombia, Burkina Faso, Australia, India and many other countries across the globe.

Further information:

More information about Rare Disease Day and the events planned in participating countries can be found at www.rarediseaseday.org

The European Union considers a disease as rare when it affects fewer than 1 in 2,000 citizens. 80% of rare diseases have a genetic origin. 5,000-7,000 rare diseases have been identified to date, affecting 30 million Europeans today.

200. Call to Action

© Rare Cancers Europe 2012. All rights reserved.
We welcome requests for permission to reprint or translate the information on this website, including the Call to Action Against Rare Cancers, for non-commercial use. However, the content, layout and logo of the website may not be copied without attribution to the campaign, and no modifications of the content, layout or logo are permitted. The cooperating organisations behind this campaign have made every effort to provide accurate information on this website. However, the cooperating organisations and corporate supporters accept no liability for any inaccuracies or omissions, nor can they accept liability for any loss or damage resulting from any inaccuracy in this information or third party information such as details on websites to which we link. The information contained on this website is for educational purposes only. For individual medical care and advice about specific conditions, please contact a doctor.